These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31314139)

  • 21. Allergic contact dermatitis due to amorolfine nail lacquer.
    Fidalgo A; Lobo L
    Dermatitis; 2004 Mar; 15(1):54. PubMed ID: 15573651
    [No Abstract]   [Full Text] [Related]  

  • 22. Allergic contact dermatitis from undecylenic acid in a commercial antifungal nail solution.
    Anguita JL; Escutia B; Marí JI; Rodríguez M; De La Cuadra J; Aliaga A
    Contact Dermatitis; 2002 Feb; 46(2):109. PubMed ID: 11918606
    [No Abstract]   [Full Text] [Related]  

  • 23. A randomized trial of amorolfine 5% solution nail lacquer combined with oral terbinafine compared with terbinafine alone in the treatment of dermatophytic toenail onychomycoses affecting the matrix region.
    Baran R; Feuilhade M; Combernale P; Datry A; Goettmann S; Pietrini P; Viguie C; Badillet G; Larnier C; Czernielewski J
    Br J Dermatol; 2000 Jun; 142(6):1177-83. PubMed ID: 10848743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is tioconazole contact dermatitis still a concern? Bringing allergic contact dermatitis caused by topical tioconazole back into the spotlight.
    Pérez-Mesonero R; Schneller-Pavelescu L; Ochando-Ibernón G; Vergara-Sánchez A; Sánchez-Herreros C; Martín-Alcalde E; Gatica-Ortega ME; Silvestre-Salvador JF; Pastor-Nieto MA
    Contact Dermatitis; 2019 Mar; 80(3):168-169. PubMed ID: 30411354
    [No Abstract]   [Full Text] [Related]  

  • 25. Loceryl nail lacquer--realization of a new galenical approach to onychomycosis therapy.
    Pittrof F; Gerhards J; Erni W; Klecak G
    Clin Exp Dermatol; 1992 Sep; 17 Suppl 1():26-8. PubMed ID: 1458660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized controlled trial comparing long-pulsed 1064-Nm neodymium: Yttrium-aluminum-garnet laser alone, topical amorolfine nail lacquer alone, and a combination for nondermatophyte onychomycosis treatment.
    Bunyaratavej S; Wanitphakdeedecha R; Ungaksornpairote C; Kobwanthanakun W; Chanyachailert P; Nokdhes YN; Patthamalai P; Tantrapornpong P; Suphatsathienkul P; Kiratiwongwan R; Limphoka P; Leeyaphan C
    J Cosmet Dermatol; 2020 Sep; 19(9):2333-2338. PubMed ID: 31925917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Laser-assisted Photodynamic Therapy or Laser-assisted Amorolfine Lacquer Delivery for Treatment of Toenail Onychomycosis: An Open-label Comparative Study.
    Koren A; Salameh F; Sprecher E; Artzi O
    Acta Derm Venereol; 2018 Apr; 98(4):467-468. PubMed ID: 29265166
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison of a fractional 2940-nm Er:YAG laser and 5% amorolfine lacquer combination therapy versus a 5% amorolfine lacquer monotherapy for the treatment of onychomycosis: a randomized controlled trial.
    Zhang J; Zhang Y; Qin J; Lu S; Cai W; Li J; Huang H; Yang S; Xi L
    Lasers Med Sci; 2021 Feb; 36(1):147-152. PubMed ID: 32557000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized trial of amorolfine 5% solution nail lacquer in association with itraconazole pulse therapy compared with itraconazole alone in the treatment of Candida fingernail onychomycosis.
    Rigopoulos D; Katoulis AC; Ioannides D; Georgala S; Kalogeromitros D; Bolbasis I; Karistinou A; Christofidou E; Polydorou D; Balkou P; Fragouli E; Katsambas AD
    Br J Dermatol; 2003 Jul; 149(1):151-6. PubMed ID: 12890209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Case of infantile onychomycosis successfully cured by 5% amorolfine nail lacquer.
    Chen S; Ran YP; Dai YL; Lama J; Hu WY
    J Paediatr Child Health; 2014 Nov; 50(11):933-4. PubMed ID: 25376356
    [No Abstract]   [Full Text] [Related]  

  • 31. A pilot, layerwise, ex vivo evaluation of the antifungal efficacy of amorolfine 5% nail lacquer vs other topical antifungal nail formulations in healthy toenails.
    Ghannoum M; Long L; Kunze G; Sarkany M; Osman-Ponchet H
    Mycoses; 2019 Jun; 62(6):494-501. PubMed ID: 30667544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative efficacy and safety of amorolfine nail lacquer 2% versus 5% once weekly.
    Lauharanta J
    Clin Exp Dermatol; 1992 Sep; 17 Suppl 1():41-3. PubMed ID: 1458664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of the Er:YAG 2940nm laser associated with amorolfine lacquer in the treatment of onychomycosis.
    Morais OO; Costa IM; Gomes CM; Shinzato DH; Ayres GM; Cardoso RM
    An Bras Dermatol; 2013; 88(5):847-9. PubMed ID: 24173203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Susceptibility testing of amorolfine, bifonazole and ciclopiroxolamine against Trichophyton rubrum in an in vitro model of dermatophyte nail infection.
    Schaller M; Borelli C; Berger U; Walker B; Schmidt S; Weindl G; Jäckel A
    Med Mycol; 2009 Nov; 47(7):753-8. PubMed ID: 19888808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New insights into the effect of amorolfine nail lacquer.
    Flagothier C; Piérard-Franchimont C; Piérard GE
    Mycoses; 2005 Mar; 48(2):91-4. PubMed ID: 15743424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A clinical study for the treatment of onychomycosis patients using a novel ROS producing onychomycosis treatment when compared against 5% amorolfine topical lacquer to reduce the visible size of infected toenails.
    Ehrensberger M; Boal CWC; Brennan J; Barrett J; Makarus J; Callanan S; Spillane E; Patton T
    J Mycol Med; 2022 Aug; 32(3):101256. PubMed ID: 35219908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hydrosoluble medicated nail lacquers: in vitro drug permeation and corresponding antimycotic activity.
    Monti D; Saccomani L; Chetoni P; Burgalassi S; Senesi S; Ghelardi E; Mailland F
    Br J Dermatol; 2010 Feb; 162(2):311-7. PubMed ID: 19886884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of topical therapies to treat onychomycosis.
    Gupta AK; Ryder JE; Baran R
    Dermatol Clin; 2003 Jul; 21(3):481-9. PubMed ID: 12956200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allergic contact dermatitis due to diethyl sebacate.
    Sasaki E; Hata M; Aramaki J; Honda M
    Contact Dermatitis; 1997 Mar; 36(3):172. PubMed ID: 9145279
    [No Abstract]   [Full Text] [Related]  

  • 40. Onychomadesis secondary to allergic contact dermatitis to tioconazole contained in a nail lacquer: Description of three cases.
    Romita P; Guarneri F; De Prezzo S; Dimauro D; Ambrogio F; Bonamonte D; Foti C
    Contact Dermatitis; 2020 Apr; 82(4):242-243. PubMed ID: 31800097
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.